CN107115349A - A kind of vitaminAD E microemulsion injections for animals and preparation method thereof - Google Patents

A kind of vitaminAD E microemulsion injections for animals and preparation method thereof Download PDF

Info

Publication number
CN107115349A
CN107115349A CN201710310433.0A CN201710310433A CN107115349A CN 107115349 A CN107115349 A CN 107115349A CN 201710310433 A CN201710310433 A CN 201710310433A CN 107115349 A CN107115349 A CN 107115349A
Authority
CN
China
Prior art keywords
parts
vitamin
vitaminad
preparation
microemulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710310433.0A
Other languages
Chinese (zh)
Inventor
张玉彦
狄良娇
刘海艳
周学章
马桂花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NINGXIA ZHIHONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Original Assignee
NINGXIA ZHIHONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGXIA ZHIHONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd filed Critical NINGXIA ZHIHONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201710310433.0A priority Critical patent/CN107115349A/en
Publication of CN107115349A publication Critical patent/CN107115349A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Abstract

The invention belongs to the technical field of field of veterinary medicine preparation, specifically Liposoluble Vitamin Injection, it is related to vitaminAD E microemulsion injections for animals and preparation method thereof.It is made up of by weight following raw materials:5 10 parts of Retinol Palmitate;Vitamin D30.1 1 parts of oil;20 50 parts of vitamin e acetate;1 part of BHA0.5;1 part of BHT0.5;12 parts of phenmethylol;2 10 parts of Tween 80;10 30 parts of absolute ethyl alcohol;10 60 parts of injection soybean oil;The present invention additionally provides the preparation method of above-mentioned parenteral solution simultaneously.The present invention is by vitamin A, vitamin D, vitamin E compound use, using the newest vitamin dosage that recommends in the world as foundation in terms of drug content, grease is selected to be used as solvent according to its dissolution properties, compound a certain amount of surfactant and cosurfactant, it is prepared for clear and bright vitaminAD E parenteral solutions, the hydrophily and dispersiveness of product are added, is conducive to body to absorb rapidly, improves bioavilability.

Description

A kind of vitaminAD E microemulsion injections for animals and preparation method thereof
Technical field
The invention belongs to the technical field of field of veterinary medicine preparation, specifically Liposoluble Vitamin Injection, it is related to dimension for animals Raw element ADE microemulsion injections and preparation method thereof.
Background technology
Although vitamin is not energy matter, nor constituting the raw material of tissue or organ, they are for thing in body Being normally carried out for matter metabolism, plays an important role in terms of the transformation of energy and the maintenance of physiological function.Vitamin A, dimension Raw element D and vitamin E belong to liposoluble vitamin.Vitamin A can not only maintain normal vision, maintain epithelial cell complete Property and promote normal development of skeleton, improve immunity of organisms, suppress tumour, and contribute to body eubolism regulate and control.Dimension life Plain D is nutrient necessary to maintaining higher mammal life, is one of most important regulatory factor of alcium and phosphor metabolization, for maintaining The life processes such as calcium phosphorus balance, skeleton development, myoneural conduction effect and cellular activity information transmission are all required.Dimension Raw element E physiological function is to promote the secretion of pituitary gonadotropic hormone, improves lipid-metabolism, reduces the generation of lipid peroxide Deng.
Liposoluble vitamin is almost insoluble in water, and the bioavilability of liquid preparation is low, therefore clinical practice is by one Definite limitation.With the development of medical sci-tech, vast pharmacy worker has continually developed micro-capsule, inclusion compound, liposome and nano-emulsion Deng vitamin novel form and new technology, hence it is evident that improve the stability and bioavilability of vitamin preparation.Conventional this of clinic Composite vitamin injection accounts for larger proportion in class injection, can meet patient daily to various vitamins under pathological state Demand or the auxiliary treatment as some diseases.Have between B B-complex class drug prescription complicated component, each component directly Or indirect interactively, stability is poor.Therefore improve solubility in water of preparation stability and liposoluble vitamin into To develop the emphasis and difficult point of such preparation.
The content of the invention
In order to overcome the above-mentioned deficiencies of the prior art, the present invention intends providing a kind of vitaminAD E microemulsion injections for animals, its It is made up of by weight following raw materials:
Vitamin A is usually coexisted with D in nature, and both, which combine, has antagonism, and oral vitamin A can excessively be done The normal absorption of vitamin D is disturbed, makes blood calcium and Phos level on a declining curve, so to control vitamin A and vitamin D Consumption is to proper ratio;When vitamin A and vitamin E are shared, vitamin E can promote body to the absorption of vitamin A, using and Liver is stored, curative effect enhancing, with synergy, and when can overcome the shortcomings of alone.
Due to the unstability of vitamin A, when the antioxidant of proper proportion, BHT and BHA compoundings are added in preparation, effect There is best protecting effect to vitamin A.
From absolute ethyl alcohol and Tween 80 compound use as solubilizer, the solubility of medicine can be increased, improved in preparation The content of main ingredient, and the absorption of enhancing medicine, so as to improve the bioavilability of medicine.
Phenmethylol is the conventional additive of injection.The purpose of phenmethylol is added, primarily to playing certain analgesia And antisepsis, and certain protective effect is played to the stability of fat-soluble injection.
Further, it is preferable to, 6.5 parts of Retinol Palmitate, vitamin D30.25 part of oil, vitamin e acetate 30 Part, 0.9 part of BHA, 0.6 part of BHT, 2 parts of phenmethylol, 4.5 parts of Tween 80,20 parts of absolute ethyl alcohol, 35 parts of injection soybean oil.
Meanwhile, the invention provides the preparation method of above-mentioned vitaminAD E microemulsion injections for animals, it includes following step Suddenly:
Retinol Palmitate, vitamin D are taken respectively by above-mentioned weight ratio3Oil, vitamin e acetate, BHA, BHT and Appropriate injection soybean oil is put into miscible in high-speed homogenization machine, formation oil phase;Added to above-mentioned oil phase and take place by above-mentioned weight ratio Side's amount Tween 80, absolute ethyl alcohol and phenmethylol, add injection soybean oil to full dose, high speed homogenization 2-5 minutes, with 2000- 5000rpm homogeneous forms colostrum in 3-5 minutes;Then, using high pressure homogenizer, under 20-100MPa pressure, N is led to2Protection, By 1-10 circulation, homogeneous emulsion is formed, the emulsion prepared is successively added using 0.45 μm and 0.22 μm of miillpore filter Press filtration, is sterilized after packing using flowing steam, and flowing steam sterilization condition is 100 DEG C, 30 minutes.
Further, whole logical N in above-mentioned preparation method2Protection.
In whole production process, protected using nitrogen, prevent the oxidation of vitamin.
The beneficial effects of the invention are as follows:By vitamin A, vitamin D, vitamin E compound use, in terms of drug content with The international newest vitamin dosage that recommends selects grease as solvent, compounded a certain amount of for foundation according to its dissolution properties Surfactant and cosurfactant, are prepared for clear and bright vitaminAD E parenteral solutions, add the hydrophily of product and disperse Property, be conducive to body to absorb rapidly, improve bioavilability.
Embodiment
The present invention is improves the solubility of preparation stability and liposoluble vitamin in water, using microemulsion technology, design VitaminAD E microemulsion injections and preparation method thereof.With reference to specific embodiment, the invention will be further described.
The vitaminAD E microemulsion injections for animals of embodiment 1., are made up of following raw material, by weight calculating:
5 parts of Retinol Palmitate, vitamin D30.1 part of oil, 20 parts of vitamin e acetate, BHA0.75 parts, BHT 0.5 part, 1 part of phenmethylol, 2 parts of Tween 80,12 parts of absolute ethyl alcohol, 59 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 2., are made up of following raw material, by weight calculating:
5.5 parts of Retinol Palmitate, vitamin D30.15 part of oil, 25 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 part, 1 part of phenmethylol, 3 parts of Tween 80,15 parts of absolute ethyl alcohol, 49 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 3., are made up of following raw material, by weight calculating:
6 parts of Retinol Palmitate, vitamin D30.2 part of oil, 28 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 Part, 1.5 parts of phenmethylol, 4 parts of Tween 80,18 parts of absolute ethyl alcohol, 41 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 4., are made up of following raw material, by weight calculating:
6.5 parts of Retinol Palmitate, vitamin D30.25 part of oil, 30 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 part, 2 parts of phenmethylol, 4.5 parts of Tween 80,20 parts of absolute ethyl alcohol, 35 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 5., are made up of following raw material, by weight calculating:
7 parts of Retinol Palmitate, vitamin D30.3 part of oil, 32 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 Part, 2 parts of phenmethylol, 5 parts of Tween 80,22 parts of absolute ethyl alcohol, 30 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 6., are made up of following raw material, by weight calculating:
7.5 parts of Retinol Palmitate, vitamin D30.35 part of oil, 35 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 part, 2 parts of phenmethylol, 5.5 parts of Tween 80,25 parts of absolute ethyl alcohol, 25 parts of injection soybean oil.
The vitaminAD E microemulsion injections for animals of embodiment 7., are made up of following raw material, by weight calculating:
8 parts of Retinol Palmitate, vitamin D30.4 part of oil, 38 parts of vitamin e acetate, BHA0.9 parts, BHT 0.6 Part, 2 parts of phenmethylol, 6 parts of Tween 80,28 parts of absolute ethyl alcohol, 16 parts of injection soybean oil.
Specific preparation method (whole N2Protection):
Retinol Palmitate, vitamin D are taken respectively by above-mentioned weight ratio3Oil, vitamin e acetate, BHA, BHT and Appropriate injection soybean oil is put into miscible in high-speed homogenization machine, formation oil phase;;Added to above-mentioned oil phase and take place by above-mentioned weight ratio Side's amount Tween 80, absolute ethyl alcohol and phenmethylol, add injection soybean oil to full dose, high speed homogenization 3 minutes is equal with 2000rpm Matter forms colostrum in 3 minutes;;Then, using high pressure homogenizer, under 50MPa pressure, N is led to2Protection, by 5 circulations, shape Into homogeneous emulsion, the emulsion prepared successively uses 0.45 μm and 0.22 μm of miillpore filter pressure filtration, is used after packing Flowing steam is sterilized, and flowing steam sterilization condition is 100 DEG C, 30 minutes.The method of described sterilizing uses filtration sterilization Mode, hundred grades of cleaning shops, i.e., after using 0.45 μm of filtering with microporous membrane, then using 0.22 μm of filtering with microporous membrane, fills N2, it is filling.Pass through different embodiments, character, drug content measure, stability and scattered feature from preparation, it is determined that most preferably Embodiment is embodiment 4.

Claims (4)

1. a kind of vitaminAD E microemulsion injections for animals, it is characterised in that:It is made up of by weight following raw materials:
2. a kind of vitaminAD E microemulsion injections for animals according to claim 1, it is characterised in that:Pressed by following raw materials Weight is than composition:
6.5 parts of Retinol Palmitate, vitamin D30.25 part of oil, 30 parts of vitamin e acetate, 0.9 part of BHA, BHT 0.6 Part, 2 parts of phenmethylol, 4.5 parts of Tween 80,20 parts of absolute ethyl alcohol, 35 parts of injection soybean oil.
3. the preparation method of a kind of vitaminAD E microemulsion injections for animals described in claim 1, it is characterised in that including such as Lower step:
Retinol Palmitate, vitamin D are taken respectively by above-mentioned weight ratio3Oil, vitamin e acetate, BHA, BHT and appropriate note Penetrate and miscible in high-speed homogenization machine, formation oil phase is put into soybean oil;Added to above-mentioned oil phase takes recipe quantity to tell by above-mentioned weight ratio Temperature 80, absolute ethyl alcohol and phenmethylol, add injection soybean oil to full dose, high speed homogenization 2-5 minutes is equal with 2000-5000rpm Matter forms colostrum in 3-5 minutes;Then, using high pressure homogenizer, under 20-100MPa pressure, N is led to2Protection, by 1-10 times Circulation, forms homogeneous emulsion, and the emulsion prepared successively uses 0.45 μm and 0.22 μm of miillpore filter pressure filtration, packing Sterilized afterwards using flowing steam, flowing steam sterilization condition is 100 DEG C, 30 minutes.
4. a kind of preparation method of vitaminAD E microemulsion injections for animals according to claim 2, it is characterised in that on State whole logical N in preparation method2Protection.
CN201710310433.0A 2017-05-05 2017-05-05 A kind of vitaminAD E microemulsion injections for animals and preparation method thereof Pending CN107115349A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710310433.0A CN107115349A (en) 2017-05-05 2017-05-05 A kind of vitaminAD E microemulsion injections for animals and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710310433.0A CN107115349A (en) 2017-05-05 2017-05-05 A kind of vitaminAD E microemulsion injections for animals and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107115349A true CN107115349A (en) 2017-09-01

Family

ID=59726759

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710310433.0A Pending CN107115349A (en) 2017-05-05 2017-05-05 A kind of vitaminAD E microemulsion injections for animals and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107115349A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498607A (en) * 2018-12-04 2019-03-22 宁夏智弘生物科技有限公司 A kind of vitaminAD E injection for animals and preparation method
CN112121006A (en) * 2020-11-02 2020-12-25 苏州素仕生物科技有限公司 Vitamin ADE composition for injection livestock and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1596882A (en) * 2004-07-22 2005-03-23 沈阳药科大学 Vitamin K1 emulsion and its freeze-dried emulsion and preparation method
CN101073580A (en) * 2007-06-22 2007-11-21 北京润德康医药技术有限公司 Compsoite vitamin injection and its production
CN101703468A (en) * 2009-11-30 2010-05-12 浙江大学 Nano-emulsion of vitamin E oil and preparation method thereof
CN102552293A (en) * 2011-12-31 2012-07-11 沈阳药科大学 Compound vitamin submicron emulsion lyophilized powder for injection and preparation method of compound vitamin submicron emulsion lyophilized powder
CN104337829A (en) * 2014-05-29 2015-02-11 西安力邦肇新生物科技有限公司 Bottled grease micro emulsion freeze-dried preparation with 13 composite vitamins

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1596882A (en) * 2004-07-22 2005-03-23 沈阳药科大学 Vitamin K1 emulsion and its freeze-dried emulsion and preparation method
CN101073580A (en) * 2007-06-22 2007-11-21 北京润德康医药技术有限公司 Compsoite vitamin injection and its production
CN101703468A (en) * 2009-11-30 2010-05-12 浙江大学 Nano-emulsion of vitamin E oil and preparation method thereof
CN102552293A (en) * 2011-12-31 2012-07-11 沈阳药科大学 Compound vitamin submicron emulsion lyophilized powder for injection and preparation method of compound vitamin submicron emulsion lyophilized powder
CN104337829A (en) * 2014-05-29 2015-02-11 西安力邦肇新生物科技有限公司 Bottled grease micro emulsion freeze-dried preparation with 13 composite vitamins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"《药剂学》" *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498607A (en) * 2018-12-04 2019-03-22 宁夏智弘生物科技有限公司 A kind of vitaminAD E injection for animals and preparation method
CN112121006A (en) * 2020-11-02 2020-12-25 苏州素仕生物科技有限公司 Vitamin ADE composition for injection livestock and preparation method thereof
CN112121006B (en) * 2020-11-02 2021-05-11 苏州素仕生物科技有限公司 Vitamin ADE composition for injection livestock and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1931232B (en) Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process
SA112340015B1 (en) Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
CN105434337A (en) Propranolol hydrochloride submicron emulsion gel and preparation method and application thereof
CN103908491B (en) A kind of composition for treating tinea pedis foot odour and preparation method thereof
WO2020073559A1 (en) Flurbiprofen axetil emulsion for injection and preparation method therefor
CN107307390A (en) Function nutrition hardening agent composition and preparation method
CN114699508A (en) Silicone gel and preparation method and application thereof
CN107115349A (en) A kind of vitaminAD E microemulsion injections for animals and preparation method thereof
KR101817514B1 (en) New use of hesperetin
CN101869302B (en) Micro-emulsion calcium preparation and preparation method as well as application thereof
CN101288682A (en) Microemulsion containing brucea javanica oil and preparation method thereof
CN109758423A (en) Use the method for vitamin K1 fat emulsion injection treatment coagulation disorders
CN101129698B (en) Eye drops containing turmeric extractive and preparation method thereof
CN103859395B (en) A kind of ubiquinone of high-absorbility 10self-emulsifying drug delivery system and preparation method thereof and application
CN102652744A (en) Modified injection containing 13 compound vitamins and preparation method thereof
CN106166123B (en) Skin care compositions, lotion with antiallergic itching-relieving efficacies and preparation method thereof
CN101810640B (en) Composite nanometer emulsion containing borneol and alum and preparation method thereof
CN101332176A (en) Medicine composition for injecting cinnarizine lipid microsphere and preparation method thereof
CN102018665B (en) Strictosamide injection and preparation method thereof
CN109939160A (en) A kind of oral solution of calm nerves and preparation method thereof
CN1431002A (en) Health care combination of propolis for reducing blood sugar and fat as well as method for mfg. its capsule
CN105030716A (en) Caffeine drug combination and preparation method thereof
CN109806226A (en) The purposes of vitamin K1 fat emulsion injection
CN109481464A (en) A kind of injection fullerene emulsion and preparation method thereof
CN104688762A (en) Medicinal composition containing 12 vitamins and used for intravenous injection

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170901